Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors.
Autor: | Hacker, U T, Gerner, F M, Büning, H, Hutter, M, Reichenspurner, H, Stangl, M, Hallek, M |
---|---|
Zdroj: | Gene Therapy. Jun2001, Vol. 8 Issue 12, p966. 3p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |